Geron Corp reports results for the quarter ended in September - Earnings Summary

Geron

28/02/2024 14:50

* Geron Corp  GERN.OQ  reported a quarterly adjusted loss
of 8
cents​​ per share for the quarter ended in September, higher
than the same quarter last year, when the company reported EPS
of -10 cents.  The mean expectation of six analysts for the
quarter was for a loss of 10 cents per share. Wall Street
expected results to range from -12 cents to -9 cents per share.
    * Revenue fell 44.8% to $164.00 thousand from a year ago;
analysts
expected $59.00 thousand. 
    * Geron Corp's reported EPS for the quarter was a loss of 8
cents​.
    * The company reported a quarterly loss of $44.81 million.
    * Geron Corp shares had fallen by 2.1% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is  "buy."

Wall Street's median 12-month price target for Geron Corp is
$5.00 
This summary was machine generated from LSEG data February 28 at
02:49 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.10          -0.08          Beat
 Jun. 30 2023      -0.08          -0.09          Missed
 Mar. 31 2023      -0.10          -0.07          Beat
 Dec. 31 2022      -0.12          -0.10          Beat